Cargando…

Mechanisms of gut microbiota-immune-host interaction on glucose regulation in type 2 diabetes

Intestinal absorption of food is one of the sources of glucose. Insulin resistance and impaired glucose tolerance caused by lifestyle and diet are the precursors of type 2 diabetes. Patients with type 2 diabetes have trouble controlling their blood sugar levels. For long-term health, strict glycemic...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yu-Dian, Liang, Feng-Xia, Tian, Hao-Ran, Luo, Dan, Wang, Ya-Yuan, Yang, Shu-Rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986296/
https://www.ncbi.nlm.nih.gov/pubmed/36891383
http://dx.doi.org/10.3389/fmicb.2023.1121695
_version_ 1784901133600292864
author Zhou, Yu-Dian
Liang, Feng-Xia
Tian, Hao-Ran
Luo, Dan
Wang, Ya-Yuan
Yang, Shu-Rui
author_facet Zhou, Yu-Dian
Liang, Feng-Xia
Tian, Hao-Ran
Luo, Dan
Wang, Ya-Yuan
Yang, Shu-Rui
author_sort Zhou, Yu-Dian
collection PubMed
description Intestinal absorption of food is one of the sources of glucose. Insulin resistance and impaired glucose tolerance caused by lifestyle and diet are the precursors of type 2 diabetes. Patients with type 2 diabetes have trouble controlling their blood sugar levels. For long-term health, strict glycemic management is necessary. Although it is thought to be well correlated with metabolic diseases like obesity, insulin resistance, and diabetes, its molecular mechanism is still not completely understood. Disturbed microbiota triggers the gut immune response to reshape the gut homeostasis. This interaction not only maintains the dynamic changes of intestinal flora, but also preserves the integrity of the intestinal barrier. Meanwhile, the microbiota establishes a systemic multiorgan dialog on the gut-brain and gut-liver axes, intestinal absorption of a high-fat diet affects the host’s feeding preference and systemic metabolism. Intervention in the gut microbiota can combat the decreased glucose tolerance and insulin sensitivity linked to metabolic diseases both centrally and peripherally. Moreover, the pharmacokinetics of oral hypoglycemic medications are also influenced by gut microbiota. The accumulation of drugs in the gut microbiota not only affects the drug efficacy, but also changes the composition and function of them, thus may help to explain individual therapeutic variances in pharmacological efficacy. Regulating gut microbiota through healthy dietary patterns or supplementing pro/prebiotics can provide guidance for lifestyle interventions in people with poor glycemic control. Traditional Chinese medicine can also be used as complementary medicine to effectively regulate intestinal homeostasis. Intestinal microbiota is becoming a new target against metabolic diseases, so more evidence is needed to elucidate the intricate microbiota-immune-host relationship, and explore the therapeutic potential of targeting intestinal microbiota.
format Online
Article
Text
id pubmed-9986296
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-99862962023-03-07 Mechanisms of gut microbiota-immune-host interaction on glucose regulation in type 2 diabetes Zhou, Yu-Dian Liang, Feng-Xia Tian, Hao-Ran Luo, Dan Wang, Ya-Yuan Yang, Shu-Rui Front Microbiol Microbiology Intestinal absorption of food is one of the sources of glucose. Insulin resistance and impaired glucose tolerance caused by lifestyle and diet are the precursors of type 2 diabetes. Patients with type 2 diabetes have trouble controlling their blood sugar levels. For long-term health, strict glycemic management is necessary. Although it is thought to be well correlated with metabolic diseases like obesity, insulin resistance, and diabetes, its molecular mechanism is still not completely understood. Disturbed microbiota triggers the gut immune response to reshape the gut homeostasis. This interaction not only maintains the dynamic changes of intestinal flora, but also preserves the integrity of the intestinal barrier. Meanwhile, the microbiota establishes a systemic multiorgan dialog on the gut-brain and gut-liver axes, intestinal absorption of a high-fat diet affects the host’s feeding preference and systemic metabolism. Intervention in the gut microbiota can combat the decreased glucose tolerance and insulin sensitivity linked to metabolic diseases both centrally and peripherally. Moreover, the pharmacokinetics of oral hypoglycemic medications are also influenced by gut microbiota. The accumulation of drugs in the gut microbiota not only affects the drug efficacy, but also changes the composition and function of them, thus may help to explain individual therapeutic variances in pharmacological efficacy. Regulating gut microbiota through healthy dietary patterns or supplementing pro/prebiotics can provide guidance for lifestyle interventions in people with poor glycemic control. Traditional Chinese medicine can also be used as complementary medicine to effectively regulate intestinal homeostasis. Intestinal microbiota is becoming a new target against metabolic diseases, so more evidence is needed to elucidate the intricate microbiota-immune-host relationship, and explore the therapeutic potential of targeting intestinal microbiota. Frontiers Media S.A. 2023-02-20 /pmc/articles/PMC9986296/ /pubmed/36891383 http://dx.doi.org/10.3389/fmicb.2023.1121695 Text en Copyright © 2023 Zhou, Liang, Tian, Luo, Wang and Yang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Zhou, Yu-Dian
Liang, Feng-Xia
Tian, Hao-Ran
Luo, Dan
Wang, Ya-Yuan
Yang, Shu-Rui
Mechanisms of gut microbiota-immune-host interaction on glucose regulation in type 2 diabetes
title Mechanisms of gut microbiota-immune-host interaction on glucose regulation in type 2 diabetes
title_full Mechanisms of gut microbiota-immune-host interaction on glucose regulation in type 2 diabetes
title_fullStr Mechanisms of gut microbiota-immune-host interaction on glucose regulation in type 2 diabetes
title_full_unstemmed Mechanisms of gut microbiota-immune-host interaction on glucose regulation in type 2 diabetes
title_short Mechanisms of gut microbiota-immune-host interaction on glucose regulation in type 2 diabetes
title_sort mechanisms of gut microbiota-immune-host interaction on glucose regulation in type 2 diabetes
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986296/
https://www.ncbi.nlm.nih.gov/pubmed/36891383
http://dx.doi.org/10.3389/fmicb.2023.1121695
work_keys_str_mv AT zhouyudian mechanismsofgutmicrobiotaimmunehostinteractiononglucoseregulationintype2diabetes
AT liangfengxia mechanismsofgutmicrobiotaimmunehostinteractiononglucoseregulationintype2diabetes
AT tianhaoran mechanismsofgutmicrobiotaimmunehostinteractiononglucoseregulationintype2diabetes
AT luodan mechanismsofgutmicrobiotaimmunehostinteractiononglucoseregulationintype2diabetes
AT wangyayuan mechanismsofgutmicrobiotaimmunehostinteractiononglucoseregulationintype2diabetes
AT yangshurui mechanismsofgutmicrobiotaimmunehostinteractiononglucoseregulationintype2diabetes